Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
Marc Scherlinger, Head of Clinic – INSERM Bettencourt, Rheumatology, Strasbourg University Hospital, shared on LinkedIn:
”Today, I had the honour of presenting an update on the role of blood platelets in autoimmune and inflammatory diseases at the European Congress of EULAR – European Alliance of Associations for Rheumatology.
For a long time, platelets were considered only as actors in hemostasis, but now appear to be major players in inflammation.
In these pathologies, they contribute in particular to the link between chronic inflammation and the increase in cardiovascular and thrombotic risk.
Our work, supported by FOREUM – Foundation for Research in Rheumatology and Inserm, sheds light on these immuno-inflammatory functions of platelets and paves the way for new therapeutic approaches to improve the management of patients with chronic inflammatory diseases, such as systemic lupus.
A big thank you to the organizers, including Professor Christophe Richez for this opportunity for scientific exchange around these clinical and translational issues.”
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 15:18Huyen Nguyen: Highlights from the NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines
-
Jun 7, 2026, 14:35Erica Wood: WHO Launches Landmark Action Framework to Secure Safe and Equitable Blood Supply Worldwide
-
Jun 7, 2026, 14:27Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes
-
Jun 7, 2026, 14:20Utsab Raj Panta: Navigating the A–E Classification in Acute Pulmonary Embolism
-
Jun 7, 2026, 14:19Ming Y Lim: The Burden and Impact of Bleeding in Newly Diagnosed Cancer Patients
-
Jun 7, 2026, 14:16What Would You Like to Know About Hemophilia Gene Therapy? – ISTH
-
Jun 7, 2026, 14:10Kamran Hajiyev: Reflections from The ICCA Stroke 2026
-
Jun 7, 2026, 14:08Faham Raza Jaffary: Beyond the Workplace – Driving Community Engagement and Empathy
-
Jun 7, 2026, 14:04Mayank Dwivedi: Transforming Outcomes Through Speed and Innovation In Stroke